Ligand Pharmaceuticals
LGND
#4123
Rank
โ‚ฌ2.24 B
Marketcap
116,40ย โ‚ฌ
Share price
-0.67%
Change (1 day)
15.80%
Change (1 year)

EPS for Ligand Pharmaceuticals (LGND)

EPS in 2025 (TTM): -6,65ย โ‚ฌ

According to Ligand Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -6,14ย โ‚ฌ. In 2024 the company made an earnings per share (EPS) of -0,04313ย โ‚ฌ a decrease over its 2023 EPS that were of 2,49ย โ‚ฌ.

EPS history for Ligand Pharmaceuticals from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-6,65ย โ‚ฌ15320.57%
2024-0,04313ย โ‚ฌ-101.73%
20232,49ย โ‚ฌ-245.96%
2022-1,71ย โ‚ฌ-157.23%
20212,98ย โ‚ฌ-2571.43%
2020-0,12ย โ‚ฌ-100.46%
201926,41ย โ‚ฌ353.48%
20185,82ย โ‚ฌ1025%
20170,52ย โ‚ฌ-700%
2016-0,08627ย โ‚ฌ-100.87%
20159,97ย โ‚ฌ1859.32%
20140,51ย โ‚ฌ5.36%
20130,48ย โ‚ฌ8.0704505322479E+18%
20120,0000000000ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Amgen
AMGN
9,53ย โ‚ฌ-255.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
-0,31ย โ‚ฌ-94.94%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
1,35ย โ‚ฌ-121.91%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
5,95ย โ‚ฌ-196.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
1,20ย โ‚ฌ-119.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
10,66ย โ‚ฌ-273.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
2,31ย โ‚ฌ-137.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
-0,02588ย โ‚ฌ-99.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
7,82ย โ‚ฌ-227.35%๐Ÿ‡บ๐Ÿ‡ธ USA